Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of gene tests to detect hereditary predisposition to chronic disease: is cost-effectiveness analysis relevant?

Medical decision making : an international journal of the Society for Medical Decision Making - 1 Jan 2000

Col Nananda F

Abstract excerpt

Screening for genetic susceptibility provides new opportunities for preventing common diseases, but whether such screening will result in substantial costs or savings is unclear. Cost-effectiveness analyses (CEAs) provide a theoretical framework for guiding clinical decisions about genetic tests. However, CEAs have been largely irrelevant in informing policy, clinical decisions, or patient demand concerning these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Testing
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cost-Benefit Analysis

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Predisposition to Disease

Share to Reproducibility of Results

Share to United States

Source

Identifiers

PMID: 14570302
DOI: 10.1177/0272989X03254456

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of gene tests to detect hereditary predisposition to chronic disease: is cost-effectiveness analysis relevant?PMID 14570302Read ↗

Genetic screening by DNA technology: a systematic review of health economic evidence.Semantic proximity Read ↗

Cancer genetics services: a systematic review of the economic evidence and issues.Semantic proximity Read ↗

Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.Semantic proximity Read ↗

Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?Semantic proximity Read ↗

Preferences for Genetic Testing to Predict the Risk of Developing Hereditary Cancer: A Systematic Review of Discrete Choice Experiments.Semantic proximity Read ↗

The use of gene tests to detect hereditary predisposition to cancer: economic considerations.Semantic proximity Read ↗

Managed care in the genomics era: assessing the cost effectiveness of genetic tests.Semantic proximity Read ↗

Value-based genomic screening: exploring genomic screening for chronic diseases using triple value principles.Semantic proximity Read ↗

Pharmacogenetics and cost-effectiveness analysis: a two-way street.Semantic proximity Read ↗

Application of population screening principles to genetic screening for adult-onset conditions.Semantic proximity Read ↗

Developing national guidance on genetic testing for breast cancer predisposition: the role of economic evidence?Semantic proximity Read ↗

Genetic testing and economic evaluations: a systematic review of the literature.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.